Li Liu1, Stephen Dodd1, Ryan Hunt1, Nikorn Pothayee1, Nadia Nadia Bouraoud1, Dragan Maric1, E Ashley Moseman1, Dorian B McGavern1, and Alan P Koretsky1
1National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, United States
Synopsis
MRI was used to follow
bleeding and T cell infiltration in mouse model of nasal infection of the brain
with VSV. Microbleeds were identified as
an early pathological and neuroimaging marker using high-resolution T2*-weighted
MRI. Adoptive transfer of virus specific CD8 T cells helped clear VSV,
decreased microbleeds but did not stop all microbleeds. Labeling T cells with MPIOs enabled MRI cell
tracking and showed the earliest T cell infiltration in the brain. CD8 T cell
infiltration and vessel rupture happened 1-day post-infection at glomerular
layer, while T cells could be detected at the center of bulb before vessel
breakdown.
INTRODUCTION:
Viral infection of the CNS is a major source of human morbidity and
mortality. How virus invades the CNS and affects the brain vascular integrity
is still unclear. Immune-CNS interactions are at the core of pathological
damage in the setting of CNS viral infections and many other neurological
disorders. To address the questions of where and how brain vessel damage first
develops, the degree of vessel damage, and the consequences of immune cell
infiltration, MRI of microbleeds and immune cell
trafficking through the whole brain may be very useful. Using microbleeds
as a marker of cerebrovasculature breakdown, we studied the relationship
between vascular disruption and CD8 T cell infiltration through T2*-weighted
MRI during neurotropic virus infection of brain using a mouse model of
vesicular stomatitis virus (VSV) intranasal infection. VSV is known to enter
the brain via pathways through the olfactory system1 but the
cascade of events throughout the brain and throughout the course of infection
has not been well described. METHODS:
Intranasal VSV infection. A dose of 3.5 x 104 PFU in 10 μL of PBS was
pipetted into each nostril. Timing is given as days post infection (dpi) and 6-dpi was
the encephalitis peak time.
OT-1 CD8 T cell labeling
with MPIO and adoptive transfer. We developed a T cell labeling technique
by using a micron-sized iron-oxide particle (MPIO), which provides high sensitivity to MRI2,3. CD8 T cells were incubated with MPIO-NH2-anti-CD3-antibody
at the ratio of 1:5 overnight. 500,000 MPIO-labeled T cells were
administered through tail vein.
MRI
study. MRI experiments
were done on an 11.7-T animal scanner. T2*-weighted 3D gradient-recalled echo (GRE)
sequences were used for acquisitions. For in-vivo imaging: isotropic
resolution=75 μm, TE/TR=10/30 ms, FA=10°, NA=3. Ex-vivo imaging: isotropic resolution=50 μm, TE/TR=20/40 ms, FA=15°, NA=12.RESULTS:
As early as 3-4 dpi, MRI detected many hypointensities on T2*
MRI that were attributed to vessel rupture and bleeding at the turbinates (Fig
1A), glomerular layer (GL) of the olfactory bulb (OB, Fig 1B,C), and
frontal brain (Fig 1D,E). 4-6 dpi, more hypointensities were detected in
granular cell layer (GCL) of OB and mid-brain. The
increasing amount of hypointensitites was quantified as a function of time (Fig
1F). Viral titers reached their peak (relative VSV RNA to actin
RNA=0.95) on 6-dpi before going down to undetectable levels by 11-dpi (Fig
1G). IHC confirmed that the MRI hypointensites were due to microbleeds which
largely co-localized with
VSV (Fig 1H).
It was next determined if increasing peripheral immune responses
by adoptive transfer of virus specific CD8 T cells would show anti-viral
therapeutic effects. MRI showed decreased bleeding in the turbinates, OB, and
brain upon T cell transfer on 6- and 11-dpi (Fig 2A-C), as quantified in
Fig 2D-F. CD8 T cells reduce viral titers on 6-dpi (Fig 2G). IHC revealed that there was a large amount of T cells, and small
amount of VSV and microbleeds in the OB on 6-dpi upon T cells transfer (Fig 2H-I). However, microbleeds were still observed, especially near the regions with
a high density of T cells.
To detect T cells by MRI early in
the course of viral infection, MPIO
particles were modified to label T cells (Fig 3A). T cell labeling efficiency was ~12% and the
majority of MPIOs were localized inside the cells (Fig 3B). MPIO-labeled
T cells show high MR sensitivity, enabling single cell detection (Fig 3C).
During MRI T cell tracking on 1-dpi, the earliest hypointensity spots were
detected near the GL (Fig 3D) as well as in the middle of OB (Fig 3E). Similar hypointensities
were not detected in
controls infused with unlabeled CD8 T cells. IHC showed that, in the GL, CD8
T cell infiltration and vessel rupture were both present at this early time
point (Fig 3F). Since MPIOs and blood give similar T2*
effects it required histology to distinguish. The hypointensity spot in the GL
was caused by the combination of MRI contrast from MPIO-labeled T cells and
microbleeds. While in the center,
MPIO-labeled T cells were detected prior to vessel breakdown (Fig 3G).DISCUSSION:
The earliest CD8 T cells infiltration was detected in the center of OB
before vessel breakdown. It is likely
that ability of virus specific T cells to traffic to sites of virus
reproduction prior to vascular damage explains why adoptive transfer greatly
reduced brain bleeding. Future studies
should enable us to track T cells to determine if they migrate from sites of
vessel disruption to other areas of the brain or if they take other routes to
get into the brain.CONCLUSION:
High resolution MRI of brain VSV infection enabled using microbleeds as
a measure of neuroinflammation and to assess the therapeutic response of
adoptive T cell transfer. MRI T cell tracking at early stages of the infection
allowed identification of sites of earliest T cell response to virus prior to
MRI detectable bleeding. The combination of MRI contrast from MPIO-labeled T
cells and microbleeds may provide an approach for early detection of
neuroinflammation. In addition to understanding timing and routes of T cell
entry into the brain, MRI cell tracking may also be helpful for optimizing cell therapies. Acknowledgements
No acknowledgement found.References
1.
Moseman
EA, Blanchard AC, Nayak D, and McGavern DB. T cell engagement of
cross-presenting microglia protects the brain from a nasal virus infection. Sci.
Immunol. 2020;5(48):eabb1817.
2.
Shapiro
EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, and Koretsky AP. MRI detection of
single particles for cellular imaging. Proc Natl Acad Sci U S A.
2004;101(30):10901-6.
3.
Pothayee
N, Cummings DM, Schoenfeld TJ, Dodd S, Cameron HA, Belluscio L, et al. Magnetic
resonance imaging of odorant activity-dependent migration of neural precursor
cells and olfactory bulb growth. Neuroimage. 2017;158:232-41.